Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Cellink (Group)

CELLINK is the leading 3D bioprinter provider and the first bioink company in the world. We focus on developing and commercializing bioprinting technologies to allow researchers to print human organs and tissues for pharmaceutical and cosmetic applications. Founded in 2016 and active in more than 50 countries, CELLINK is changing the future of medicine as we know it. Visit www.cellink.com to learn more. CELLINK is listed on Nasdaq First North under CLNK. Erik Penser Bank AB is the company’s certified adviser, available by phone at +46 846 383 00 and by email at certifiedadviser@penser.se. *

 

Period Start 2016-01-01 established
Products Industry 3D bioprinting
  Industry 2 single cell dispenser
Persons Person Gatenholm, Erik (Cellink 201908 CEO + Co-Founder)
  Person 2 Danielsson, Gusten (Cellink 201908 CFO + Co-Founder)
     
Region Region Göteborg (Gothenburg)
  Country Sweden
  Street 20 Arvid Wallgrens Backe
  City 41346 Göteborg
  Tel +46-73-267-0000
    Address record changed: 2020-12-02
     
Basic data Employees F: 1,001 to 5,000 (2019-08-31)
  Currency SEK
  Annual sales 105,457,000 (sales, net, consolidated (2018/19) 2019-08-31)
  Profit 581,000 (2019-08-31)
  Cash 198,770,000 (2019-08-31)
     
    * Document for �About Section�: Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg.
     
   
Record changed: 2021-04-01

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Cellink (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80




» top